Embolism

Women with severe maternal morbidity after first childbirth have a lower likelihood of pursuing subsequent births, highlighting the need for reproductive counseling and better prenatal care, according to study results published in JAMA.

Arrow International, a subsidiary of Teleflex, has issued a recall of its radial artery and arterial line catheterization kits due to increased resistance that may cause injury to the vessel wall, vasospasm, embolism or death.

Fresenius Medical Care is recalling millions of single use sterile syringes used during hemodialysis treatments because of leakages, the company reported.

A next-generation left atrial appendage closure device conferred low rates of adverse events and peri-device leak in a real-world cohort at 45 days, according to results of the SURPASS study.

LAA closure (Amplatzer Amulet, Abbott, or Watchman, Boston Scientific) or non-vitamin K antagonist oral anticoagulants in patients with AF.

Cardiovascular Systems Inc. announced a recall of its embolic protection device due to complaints of filter breakage during retrieval of lower limb blood clots associated with atherectomy procedures in lower limbs.

Compared with manual contact catheters, robotic magnetic navigation reduced risk for silent cerebral embolism after atrial fibrillation ablation procedures, researchers reported in Frontiers in Cardiovascular Medicine.

Among patients with atrial fibrillation at high risk for stroke, left atrial appendage closure remained noninferior to direct oral anticoagulation for preventing major CV and neurological events out to 4 years.

Continuous implantable loop recorder monitoring resulted in a threefold increase in atrial fibrillation detection and subsequent anticoagulation initiation, but failed to reduce risk for stroke or systemic embolism in high-risk patients.

After an initial embolic stroke of undetermined source, or ESUS, the most prevalent recurrent infarct was another ESUS, according to an analysis of the NAVIGATE-ESUS trial.